<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    AcelRx Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About AcelRx Pharmaceuticals, Inc.

    AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $95,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Vincent J. Angotti
    • FOUNDED
      2005
    • EMPLOYEES
      51-100
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Portola Pharmaceuticals, Inc.

    Portola Pharmaceuticals, Inc.

    Portola Pharmaceuticals is a global, commercial-stage biopharmaceutical company fo...

    Portola Pharmaceuticals is a global, commercial...

    Filing Type:    PU
    Genetic Technologies Ltd

    Genetic Technologies Ltd

    Genetic Technologies is a leader in the development of genetic technology. Our tes...

    Genetic Technologies is a leader in the develop...

    Filing Type:    PU
    Kindred Biosciences, Inc.

    Kindred Biosciences, Inc.

    KindredBio is focused on bringing breakthrough human products and innovative new t...

    KindredBio is focused on bringing breakthrough ...

    Filing Type:    PU
    Eyenovia, Inc.

    Eyenovia, Inc.

    Eyenovia is a late-stage ophthalmic biopharmaceutical company developing breakthro...

    Eyenovia is a late-stage ophthalmic biopharmace...

    Filing Type:    PU
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    ZENII, LLC

    ZENII, LLC

    Intrommune Therapeutics is a New York City-based biopharmaceutical company develop...

    Intrommune Therapeutics is a New York City-base...

    Amount Raised:    $154,555.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.